(Q45373655)

English

Polycystic kidney disease: Tolvaptan in ADPKD-TEMPO 3:4 trial results.

scientific article published on 27 November 2012

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23183839

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23183839%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 February 2020

title

Polycystic kidney disease: Tolvaptan in ADPKD-TEMPO 3:4 trial results (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23183839

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23183839%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 February 2020

main subject

polycystic kidney disease

1 reference

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23183839

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23183839%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 February 2020

author name string

Rebecca Kelsey

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23183839

retrieved

13 December 2017

language of work or name

English

0 references

publication date

27 November 2012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23183839

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23183839%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 February 2020

published in

Nature Reviews Nephrology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23183839

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23183839%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 February 2020

volume

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23183839

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23183839%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 February 2020

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23183839

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23183839%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 February 2020

page(s)

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23183839

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23183839%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 February 2020

cites work

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.236

retrieved

31 March 2020

Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/23183839

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

(Q45373655)

Polycystic kidney disease: Tolvaptan in ADPKD-TEMPO 3:4 trial results.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)